Alpelisib Plus Fulvestrant in <i>PIK3CA</i> -Altered and <i>PIK3CA</i> -Wild-Type Estrogen Receptor–Positive Advanced Breast Cancer

2018257 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov identifier: NCT01219699.

Good health and well-being

Published in: JAMA Oncology

Volume 5, Issue 2, pp. e184475-e184475

Field-Weighted Citation Impact: 21.62